Profile data is unavailable for this security.
About the company
EssilorLuxottica SA is a France-based ophthalmic company. The Company designs, distributes, manufactures, and markets a range of lenses, frames, and sunglasses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. EssilorLuxottica's assets include recognized brands, such as Ray-Ban and Oakley for eyewear, Varilux and Transitions for ophthalmic optical technologies, and Sunglass Hut and Lenscrafters for international distribution networks.
- Revenue in EUR (TTM)25.40bn
- Net income in EUR2.29bn
- Incorporated1971
- Employees191.71k
- LocationEssilorLuxottica SA147 rue de ParisCHARENTON-LE-PONT 94220FranceFRA
- Phone+33 149774224
- Fax+33 149774420
- Websitehttps://www.essilorluxottica.com/
Mergers & acquisitions
| Acquired company | EL:PAR since announced | Transaction value |
|---|---|---|
| NUANCE Hearing Ltd | 15.63% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sartorius Stedim Biotech SA | 2.72bn | 254.70m | 20.27bn | 10.60k | 76.27 | 5.01 | 39.21 | 7.46 | 2.73 | 2.73 | 29.11 | 41.57 | 0.4013 | 1.60 | 7.82 | 254,764.60 | 3.81 | 11.87 | 4.55 | 15.12 | 42.98 | 50.96 | 9.49 | 17.44 | 1.24 | 6.59 | 0.452 | 18.73 | -20.53 | 18.02 | -64.65 | 8.28 | 21.82 | 3.90 |
| Straumann Holding AG | 2.46bn | 251.33m | 22.33bn | 11.11k | 88.93 | 11.90 | 57.98 | 9.06 | 1.54 | 1.54 | 15.11 | 11.52 | 0.7204 | 1.81 | 4.29 | 217,105.00 | 7.37 | 10.68 | 9.86 | 13.63 | 74.15 | 74.95 | 10.23 | 15.15 | 1.43 | 6.72 | 0.1968 | 37.50 | 3.92 | 12.08 | -43.40 | -2.04 | 11.54 | 10.12 |
| Coloplast A/S | 3.35bn | 652.68m | 25.98bn | 15.75k | 41.09 | 13.71 | 32.39 | 7.75 | 22.44 | 22.44 | 115.20 | 67.27 | 0.5794 | 2.40 | 5.99 | 1,593,232.00 | 11.28 | 20.45 | 17.11 | 29.69 | 66.74 | 67.91 | 19.47 | 21.73 | 0.3462 | 11.08 | 0.5885 | 91.08 | 8.51 | 8.29 | 1.64 | 4.46 | 13.15 | 5.59 |
| Siemens Healthineers AG | 21.78bn | 1.52bn | 59.51bn | 71.40k | 39.02 | 3.30 | 19.53 | 2.73 | 1.35 | 1.35 | 19.33 | 15.98 | 0.4727 | 3.19 | 3.88 | 306,746.50 | 3.33 | 4.88 | 4.52 | 6.60 | 35.89 | 37.82 | 7.04 | 9.22 | 0.75 | 23.00 | 0.4721 | 54.89 | -0.1566 | 10.05 | -25.96 | 3.59 | 9.60 | 18.98 |
| EssilorLuxottica SA | 25.40bn | 2.29bn | 92.90bn | 191.71k | 40.28 | 2.42 | 17.29 | 3.66 | 5.08 | 5.08 | 56.34 | 84.59 | 0.4195 | 3.46 | 9.02 | 132,468.50 | 4.01 | 2.73 | 4.80 | 3.21 | 62.22 | 61.28 | 9.55 | 7.52 | 0.7156 | 42.29 | 0.2306 | 75.45 | 3.68 | 18.58 | 6.37 | 16.15 | 16.61 | 14.13 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 05 Apr 2024 | 10.78m | 2.38% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 9.29m | 2.05% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 7.38m | 1.63% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 5.02m | 1.11% |
| Fidelity Management & Research Co. LLCas of 04 Apr 2024 | 4.27m | 0.94% |
| Canada Pension Plan Investment Boardas of 31 Mar 2023 | 3.98m | 0.88% |
| MFS International (UK) Ltd.as of 29 Feb 2024 | 3.66m | 0.81% |
| Comgest SAas of 29 Dec 2023 | 3.35m | 0.74% |
| Amundi Asset Management SA (Investment Management)as of 31 Dec 2022 | 3.15m | 0.69% |
| BlackRock Advisors (UK) Ltd.as of 04 Apr 2024 | 3.11m | 0.69% |
